S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   271.90 (-0.21%)
AAPL   459.01 (-0.22%)
MSFT   208.62 (-0.04%)
FB   260.56 (-0.28%)
GOOGL   1,503.70 (-0.85%)
AMZN   3,138.10 (-0.73%)
NVDA   461.38 (+0.80%)
CGC   17.17 (-0.87%)
BABA   253.48 (-0.09%)
TSLA   1,648.75 (+1.71%)
GE   6.64 (+0.61%)
MU   45.66 (-1.04%)
AMD   81.37 (-0.57%)
T   29.96 (+0.17%)
F   7.03 (+0.14%)
ACB   10.62 (+4.32%)
GILD   68.58 (+0.59%)
NFLX   482.32 (+0.21%)
DIS   130.22 (-0.57%)
BAC   26.38 (+0.11%)
BA   177.74 (+1.72%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   271.90 (-0.21%)
AAPL   459.01 (-0.22%)
MSFT   208.62 (-0.04%)
FB   260.56 (-0.28%)
GOOGL   1,503.70 (-0.85%)
AMZN   3,138.10 (-0.73%)
NVDA   461.38 (+0.80%)
CGC   17.17 (-0.87%)
BABA   253.48 (-0.09%)
TSLA   1,648.75 (+1.71%)
GE   6.64 (+0.61%)
MU   45.66 (-1.04%)
AMD   81.37 (-0.57%)
T   29.96 (+0.17%)
F   7.03 (+0.14%)
ACB   10.62 (+4.32%)
GILD   68.58 (+0.59%)
NFLX   482.32 (+0.21%)
DIS   130.22 (-0.57%)
BAC   26.38 (+0.11%)
BA   177.74 (+1.72%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   271.90 (-0.21%)
AAPL   459.01 (-0.22%)
MSFT   208.62 (-0.04%)
FB   260.56 (-0.28%)
GOOGL   1,503.70 (-0.85%)
AMZN   3,138.10 (-0.73%)
NVDA   461.38 (+0.80%)
CGC   17.17 (-0.87%)
BABA   253.48 (-0.09%)
TSLA   1,648.75 (+1.71%)
GE   6.64 (+0.61%)
MU   45.66 (-1.04%)
AMD   81.37 (-0.57%)
T   29.96 (+0.17%)
F   7.03 (+0.14%)
ACB   10.62 (+4.32%)
GILD   68.58 (+0.59%)
NFLX   482.32 (+0.21%)
DIS   130.22 (-0.57%)
BAC   26.38 (+0.11%)
BA   177.74 (+1.72%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   271.90 (-0.21%)
AAPL   459.01 (-0.22%)
MSFT   208.62 (-0.04%)
FB   260.56 (-0.28%)
GOOGL   1,503.70 (-0.85%)
AMZN   3,138.10 (-0.73%)
NVDA   461.38 (+0.80%)
CGC   17.17 (-0.87%)
BABA   253.48 (-0.09%)
TSLA   1,648.75 (+1.71%)
GE   6.64 (+0.61%)
MU   45.66 (-1.04%)
AMD   81.37 (-0.57%)
T   29.96 (+0.17%)
F   7.03 (+0.14%)
ACB   10.62 (+4.32%)
GILD   68.58 (+0.59%)
NFLX   482.32 (+0.21%)
DIS   130.22 (-0.57%)
BAC   26.38 (+0.11%)
BA   177.74 (+1.72%)
Log in

NASDAQ:CYANCyanotech Stock Price, Forecast & News

$2.32
-0.02 (-0.85 %)
(As of 08/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.32
Now: $2.32
$2.32
50-Day Range
$2.18
MA: $2.32
$2.67
52-Week Range
$1.82
Now: $2.32
$3.25
Volume464 shs
Average Volume11,270 shs
Market Capitalization$13.98 million
P/E Ratio33.15
Dividend YieldN/A
Beta0.6
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. Cyanotech Corporation sells its products as packaged consumer products through distributors, retailers, and online channels, as well as directly to consumers; and in bulk quantities to manufacturers, formulators, and distributors. The company was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.61 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CYAN
CUSIPN/A
Phone808-326-1353

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$31.90 million
Cash Flow$0.43 per share
Book Value$2.67 per share

Profitability

Net Income$390,000.00

Miscellaneous

Employees118
Market Cap$13.98 million
Next Earnings Date11/10/2020 (Estimated)
OptionableNot Optionable
$2.32
-0.02 (-0.85 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CYAN News and Ratings via Email

Sign-up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cyanotech (NASDAQ:CYAN) Frequently Asked Questions

How has Cyanotech's stock been impacted by Coronavirus (COVID-19)?

Cyanotech's stock was trading at $1.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CYAN shares have increased by 16.6% and is now trading at $2.32.
View which stocks have been most impacted by COVID-19
.

When is Cyanotech's next earnings date?

Cyanotech is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Cyanotech
.

How were Cyanotech's earnings last quarter?

Cyanotech Corp (NASDAQ:CYAN) released its quarterly earnings data on Tuesday, August, 11th. The biotechnology company reported $0.02 earnings per share for the quarter. Cyanotech had a net margin of 1.21% and a return on equity of 2.50%.
View Cyanotech's earnings history
.

Has Cyanotech been receiving favorable news coverage?

Headlines about CYAN stock have been trending extremely negative on Friday, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cyanotech earned a media sentiment score of -4.0 on InfoTrie's scale. They also gave press coverage about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term.
View the latest news about Cyanotech
.

Are investors shorting Cyanotech?

Cyanotech saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 6,600 shares, an increase of 17.9% from the May 31st total of 5,600 shares. Based on an average daily volume of 7,700 shares, the short-interest ratio is presently 0.9 days. Currently, 0.2% of the shares of the stock are short sold.
View Cyanotech's Short Interest
.

Who are some of Cyanotech's key competitors?

What other stocks do shareholders of Cyanotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cyanotech investors own include Allena Pharmaceuticals (ALNA), Clarivate Analytics (CCC), AbbVie (ABBV), Acasti Pharma (ACST), Akari Therapeutics (AKTX), Athersys (ATHX), Avinger (AVGR), Bausch Health Companies (BHC), Biocept (BIOC) and BIOLINERX LTD/S (BLRX).

Who are Cyanotech's key executives?

Cyanotech's management team includes the following people:
  • Mr. Mawae R. Morton, Chief Exec. Officer (Age 52)
  • Dr. Gerald R. Cysewski Ph.D., Co-Founder, Pres & Vice Chairman (Age 70)
  • Mr. Brian Brett Orlopp, VP of Fin. & CFO and Sec.
  • Mr. Glenn D. Jensen, VP of Manufacturing & Infrastructure (Age 61)

What is Cyanotech's stock symbol?

Cyanotech trades on the NASDAQ under the ticker symbol "CYAN."

Who are Cyanotech's major shareholders?

Cyanotech's stock is owned by many different retail and institutional investors. Top institutional investors include Heritage Investors Management Corp (0.22%).
View institutional ownership trends for Cyanotech
.

Which major investors are buying Cyanotech stock?

CYAN stock was purchased by a variety of institutional investors in the last quarter, including Heritage Investors Management Corp.
View insider buying and selling activity for Cyanotech
.

How do I buy shares of Cyanotech?

Shares of CYAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cyanotech's stock price today?

One share of CYAN stock can currently be purchased for approximately $2.32.

How big of a company is Cyanotech?

Cyanotech has a market capitalization of $13.98 million and generates $31.90 million in revenue each year. Cyanotech employs 118 workers across the globe.

What is Cyanotech's official website?

The official website for Cyanotech is www.cyanotech.com.

How can I contact Cyanotech?

Cyanotech's mailing address is 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA KONA HI, 96740. The biotechnology company can be reached via phone at 808-326-1353 or via email at [email protected]

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.